Abstract
Age-related macular degeneration (AMD) is the leading cause of visual impairment in the western world, causing significant reduction in quality of life. Despite treatment advances, the burden of visual impairment caused by AMD continues to rise. In addition to traditional low vision rehabilitation and support, optical and electronic aids, and strategies to enhance the use of peripheral vision, implantable telescopic devices have been indicated as a surgical means of enhancing vision. Here we examine the literature on commercially available telescopic devices discussing their design, mode of action, surgical procedure and published outcomes on visual acuity, quality of life, surgical complication rates and cost effectiveness data where available.Funding Article processing charges were funded by VisionCare Inc.
Highlights
Age-related macular degeneration (AMD) is the leading cause of visual impairment in the western world, causing significant reduction in quality of life [1]
Though significant advances in treatment for neovascular AMD have been made with the introduction of anti-vascular endothelial growth factor (VEGF) intravitreal injections [3, 4], a sizeable proportion do not respond
Good visual rehabilitation can help people with AMD make best use of the sight they retain and help them maintain an Ophthalmol Ther (2018) 7:33–48 active life [10]; a review of low vision rehabilitation service provision highlights a paucity of well designed high quality research on the effectiveness and in particular cost effectiveness of current low vision services [11]
Summary
Age-related macular degeneration (AMD) is the leading cause of visual impairment in the western world, causing significant reduction in quality of life [1]. Though significant advances in treatment for neovascular AMD have been made with the introduction of anti-vascular endothelial growth factor (VEGF) intravitreal injections [3, 4], a sizeable proportion do not respond. Good visual rehabilitation can help people with AMD make best use of the sight they retain and help them maintain an Ophthalmol Ther (2018) 7:33–48 active life [10]; a review of low vision rehabilitation service provision highlights a paucity of well designed high quality research on the effectiveness and in particular cost effectiveness of current low vision services [11]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
